Literature DB >> 19367127

Skin cancer: new markers for better prevention.

Rüdiger Greinert1.   

Abstract

Skin cancer is the most frequent cancer in the white population worldwide. Incidence of basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and malignant melanoma (MM) is still increasing. This trend can be counteracted by means of primary and secondary prevention because the main risk factor for skin cancer - UV-radiation - is known, and, early detected, skin cancer can be cured successfully. For early detection of skin cancer suitable risk (group) markers have to be used to identify persons at risk. In order to increase the sensitivity and specificity of early detection efforts (screening programs) new molecular markers or biomarkers should be used in the future in the field of molecular epidemiology. In this review the skin cancer problem is summarized and the possible use of new biomarkers for skin cancer development, progression, metastasis and prognosis is discussed. The review focuses on results of gene expression profiling using array techniques and the new possibilities for the use of epigenetic biomarkers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367127     DOI: 10.1159/000201675

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  10 in total

1.  Selenium-containing histone deacetylase inhibitors for melanoma management.

Authors:  Raghavendra Gowda; Subbarao V Madhunapantula; Dhimant Desai; Shantu Amin; Gavin P Robertson
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

Review 2.  UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer.

Authors:  Gerd P Pfeifer; Ahmad Besaratinia
Journal:  Photochem Photobiol Sci       Date:  2011-08-01       Impact factor: 3.982

3.  UVA and UVB irradiation differentially regulate microRNA expression in human primary keratinocytes.

Authors:  Anne Kraemer; I-Peng Chen; Stefan Henning; Alexandra Faust; Beate Volkmer; Michael J Atkinson; Simone Moertl; Ruediger Greinert
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

4.  Different types of DNA damage play different roles in the etiology of sunlight-induced melanoma.

Authors:  David L Mitchell; André A Fernandez
Journal:  Pigment Cell Melanoma Res       Date:  2010-10-29       Impact factor: 4.693

5.  Brain and muscle Arnt-like protein-1 (BMAL1) controls circadian cell proliferation and susceptibility to UVB-induced DNA damage in the epidermis.

Authors:  Mikhail Geyfman; Vivek Kumar; Qiang Liu; Rolando Ruiz; William Gordon; Francisco Espitia; Eric Cam; Sarah E Millar; Padhraic Smyth; Alexander Ihler; Joseph S Takahashi; Bogi Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

6.  Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitis.

Authors:  Detlef Becker; Elise Langer; Martin Seemann; Gunda Seemann; Isabel Fell; Joachim Saloga; Stephan Grabbe; Esther von Stebut
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

7.  Nucleotide excision repair deficiency in melanoma in response to UVA.

Authors:  Heather C Murray; Vicki E Maltby; Doug W Smith; Nikola A Bowden
Journal:  Exp Hematol Oncol       Date:  2016-02-24

8.  The response of human skin commensal bacteria as a reflection of UV radiation: UV-B decreases porphyrin production.

Authors:  Yanhan Wang; Wenhong Zhu; Muya Shu; Yong Jiang; Richard L Gallo; Yu-Tsueng Liu; Chun-Ming Huang
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

9.  Microbiopsy engineered for minimally invasive and suture-free sub-millimetre skin sampling.

Authors:  Lynlee L Lin; Tarl W Prow; Anthony P Raphael; Robert L Harrold Iii; Clare A Primiero; Alexander B Ansaldo; H Peter Soyer
Journal:  F1000Res       Date:  2013-05-02

Review 10.  Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?

Authors:  António Castanheira; Paula Boaventura; Manuel Pais Clemente; Paula Soares; Alberto Mota; José Manuel Lopes
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-07-31       Impact factor: 2.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.